Christopher Lindblom Email and Phone Number
Christopher Lindblom work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Christopher Lindblom personal email
Christopher Lindblom phone numbers
Vice President of Finance and OperationsProven track record of leadership within the life sciences industry, including Millennium Pharmaceuticals, IFM Therapeutics (Atlas Ventures), Warp Drive Bio and Cedilla Therapeutics (Third Rock Ventures), Cogen Immune Medicine (Flagship Pioneering), Infinity Pharmaceuticals, and BIND Therapeutics. Member of executive management team and trusted advisor to CEO, CFO and Board of Directors on a wide range of financial and operating issues as well as developing, influencing and executing overall strategy. Team leader and mentor.Core specialties include:Accounting, long-range planning, financial planning & analysisProcess improvements, including alignment of financial and procurement information systemsSEC (including pre-clearance process) and management reporting and analyticsTreasury / investment portfolio management, tax planning and compliance, insuranceStrategic collaborations (including Novartis, J&J, Pfizer, and AZ)Financings (~$400M since 2012) at private and public companiesM&A (IFM Due by Novartis; Warp Drive Bio by Revolution Medicines; Cogen by Torque to form Repertoire Immune)
Profound Therapeutics
View- Website:
- profoundtx.com
- Employees:
- 45
-
Profound TherapeuticsBoston, Massachusetts, United States
-
Vice President Of Finance And TreasurerIfm Therapeutics Jun 2022 - Aug 2024Boston, Massachusetts, UsCritical role for Finance and Legal due diligence related to Novartis M&A for IFM Due (STING program). Key contact with Novartis throughout collaboration, acquisition and transition. Management team member and presenter at Board meetings. Sublet unused space in 2022 through end of facility lease in 2024. -
Vice President Of FinanceCedilla Therapeutics Jul 2021 - Jun 2022Cambridge, Massachusetts, UsMember of Management Team. Played key role in equity financing and amending venture debt agreement. -
Vice President Of Finance And TreasurerIfm Therapeutics May 2020 - Jul 2021Boston, Massachusetts, UsMember of Management Team who made several operational improvements including implementing Prendio, further optimizing NetSuite to include all subsidiaries for the full LLC structure and using Carta for the first time on several legal entities. Led lean team of consultants to better serve the company's needs. Presented at Board meetings. Played key role in equity financing and amending venture debt agreement.
-
Vice President Of Finance, Secretary And TreasurerCogen Immune Medicine, Inc. Jan 2019 - Feb 2020Executed M&A with another Flagship company (Torque) to form Repertoire Immune Medicines and implemented financial integration activities. Worked closely with Flagship and investors on $100+ million Series B equity raise. Created long range financial plan highlighting value inflection points and capital requirements. Played key role on Management team. Built finance operations (budgeting, forecasting and accounting) including implementing Oracle NetSuite.
-
Vice President Of Finance And OperationsWarp Drive Bio, Inc. Mar 2017 - Dec 2018Played significant part with CEO in M&A with Revolution Medicines, Inc. during Series B equity raise process. Member of Management Team who built strong relationships with R&D. Led long-range planning and budgeting / forecasting with focus on value creation inflection points. Presented at board meetings and managed yearly audit / audit committee processes. Created lean team of consultants to efficiently and effectively improve financial operations.
-
Vice President Of Finance And TreasurerInfinity Pharmaceuticals Apr 2016 - Oct 2016Cambridge, Massachusetts, UsPlanned and organized financial infrastructure and processes in preparation for pharmaceutical commercial launch until dramatic downsizing after registration oriented data read-outs and termination of strategic collaboration with AbbVie. Identified and retained critical finance roles to maintain transition to a smaller company focused on an Phase 1 program while remaining Sarbanes-Oxley compliant. Led all Audit Committee meetings. Built and summarized “free cash analysis” to assist management and the board in scenario planning to support strategic decisions in the context of downsizing. -
Senior Vice President Of Finance And AdministrationBind Therapeutics Mar 2014 - Apr 2016Cambridge, Ma, UsPlayed key role in confidentially marketed equity raise, at-the-market facility and venture debt. Spoke regularly on quarterly earnings conference calls with investors. Strong member of management team. Led all Audit Committee meetings and presented at quarterly Board of Director meetings.Reshaped and supervised diverse team including the Controller, Director of FP&A, Senior Corporate Counsel and Head of Facilities, as well as managing outsourced IT operations. Transformed company and finance operations dramatically with selecting and implementing new purchasing system (eRequester) and general ledger (Great Plains) revamping. -
Vice President Of FinanceOvascience May 2013 - Mar 2014Built finance team and efficiently executed Sarbanes-Oxley compliance and SEC / management reporting. Prime contributor in all Audit Committee meetings and presenter at Board of Director meetings. Finance member of the executive management team.Selected and implemented NetSuite cloud ERP system to replace QuickBooks. Strengthened income statement and long range plannning and created cash and balance sheet budgeting and forecasting.
-
Vice President, Accounting And FinanceInfinity Pharmaceuticals Oct 2006 - May 2013Cambridge, Massachusetts, UsBuilt in three months’ time, for this oncology-focused company that went public via a reverse merger in 2006, a Sarbanes-Oxley compliant accounting team and robust SEC / management reporting processes. Key leader in team that successfully executed two confidentially marketing equity offerings exceeding $250M in total proceeds. Prime contributor in all Audit Committee meetings and presenter at Board of Director meetings. Led overall company goals process for three years ensuring budget and goals were aligned. Redesigned income statement and long range planning and transformed cash and balance sheet budgeting to successfully manage operating expenses and ending cash and investments within public guidance. Carefully assembled and managed team.
-
Assistant ControllerMillennium Pharmaceuticals Apr 2002 - Oct 2006Cambridge, Ma, UsRevamped accounting, cost accounting and accounts payable teams and processes to enhance alignment and performance both with business groups and with Financial Planning in a highly matrixed organization (functions as well as products). Led product sales accounting (returns reserve, chargeback reserve, revenue recognition, and government pricing). Implemented Oracle 11i ERP system, focused on general ledger module both for US and UK operations and Concur travel and expense system for over one thousand employees. Redesigned clinical trial accrual and clinical payment processes with R&D buy-in and support. -
Manager, Financial PlanningParametric Technology Corporation 2000 - 2002Boston, Massachusetts, UsUpgraded and executed financial and operating reporting and metrics for sales organization. Modeled potential acquisitions and competitive analysis. -
Manager Of Financial ReportingHarcourt General 1997 - 2000Prepared financial reporting packages for management and SEC reporting. Supported public debt offering and The Neiman Marcus Group, Inc. spin-off. -
Senior AccountantPricewaterhousecoopers 1993 - 1997GbServed as Field Team Leader on assurance engagements for High-Tech, Manufacturing and Non-Profit.
Christopher Lindblom Skills
Christopher Lindblom Education Details
-
Boston College Carroll School Of ManagementMaster Of Business Administration - Mba -
Syracuse University - Martin J. Whitman School Of ManagementAccounting
Frequently Asked Questions about Christopher Lindblom
What company does Christopher Lindblom work for?
Christopher Lindblom works for Profound Therapeutics
What is Christopher Lindblom's role at the current company?
Christopher Lindblom's current role is Vice President of Finance and Operations.
What is Christopher Lindblom's email address?
Christopher Lindblom's email address is cl****@****atx.com
What is Christopher Lindblom's direct phone number?
Christopher Lindblom's direct phone number is +161749*****
What schools did Christopher Lindblom attend?
Christopher Lindblom attended Boston College Carroll School Of Management, Syracuse University - Martin J. Whitman School Of Management.
What skills is Christopher Lindblom known for?
Christopher Lindblom has skills like Mergers And Acquisitions, Biotechnology, Strategic Financial Planning, Finance, Treasury, Insurance, Leadership, Financial Reporting, Sarbanes Oxley Act, Financial Modeling, Tax, Us Gaap.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial